This study provides in vivo data for synovial fluid PPi and NTPase. It suggests that factors other than PPi need to be considered in a study of crystal associated arthropathy. Clinical inflammation, as well as diagnosis, is important in synovial fluid studies.
(itmol PPi/30 mi/mg protein) was pyrophosphate arthropathy> osteoarthritis> rheumatoid arthritis (median PPi, NTPase respectively: for pyrophosphate arthropathy 15-9, 0 45; for osteoarthritis 9-3, 0.25; for rheumatoid arthritis 4-4, 0-18), with significant differences between all groups. In pyrophosphate arthropathy both PPi (,tmol/l) and NTPase (,umol PPi/30 min/mg protein) were higher than normal (15.9, 0 45 v 8-6, 0-2 respectively), but findings in osteoarthritis did not differ from normal. The inflammatory state of the knee had a distinct but variable effect on synovial fluid findings in rheumatoid arthritis and pyrophosphate arthropathy, but not in osteoarthritis. There was no correlation of either PPi or NTPase with age, or between PPi and NTPase in any group.
This study provides in vivo data for synovial fluid PPi and NTPase. It suggests that factors other than PPi need to be considered in a study of crystal associated arthropathy. Clinical inflammation, as well as diagnosis, is important in synovial fluid studies.
Although intra-articular deposition of crystalline calcium pyrophosphate dihydrate (CPPD) most commonly occurs as an identical, age related phenomenon,' such deposition has been associated with 'pyrophosphate arthropathy', a subset of osteoarthritis characterised by typical clinical and radiographic features.2 3 The relation between crystals, inflammation, and arthropathy, however, remains uncertain. [1] [2] [3] The two principal hypotheses suggest that CPPD crystals either are (a) primary pathogenic particles or (b) 6 Briefly, the sample PPi was allowed to react with added tritiated uridine diphosphogluconate, and the product, glucose-1-phosphate, was converted to a labelled, stable, recoverable product-tritiated 6-phosphogluconate (each sample assayed in duplicate2932).
The PPi assay mixture contained 57 mM TRIS acetate; 5-2 mM magnesium acetate; 4 pM nicotinamide-adenine dinucleotide phosphate; 18-6 FM glucose-i ,6-diphosphate; 7-5 .M uridine diphosphogluconate; 0-4 U/I glucose-6-phosphate dehydrogenase; 0-2 U/l phosphoglucomutase; 0 136 U/l uridine diphosphoglucose pyrophosphorylase; and tritiated uridine diphosphogluconate (specific activity The incubation mixture contained 5-4 mM KCI; 0-8 mM MgSO4; 1-8 mM CaCl2; 0-118 mM NaCl; 1 mM NaH2PO4; 5-56 mM glucose; and 20 mM HEPES (N-2-hydroxyethylpiperazine-N'-2-ethanesulphonic acid). The mixture was held for 30 minutes in a shaking water bath and then incubation was terminated by cooling on ice and by addition of 0 -I ml trichloroacetic acid (50% w/v). After centrifugation at 2500 g for 15 minutes at 4°C trichloroacetic acid was removed by the addition of one volume of tri-noctylamine dissolved in three volumes of 1,1,2-trichlorofluoroethane. This mixture draws the trichloroacetic acid into the lower organic layer. (8) [imol/I respectively); correspondingly higher NTPase activity was found in pyrophosphate arthropathy. Silcox 
